卡诺普“踩线”申报港股IPO：营收最低毛利率最高 海外占比下滑、高度依赖政府补贴

Core Viewpoint - Chengdu Kanopu Robot Technology Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, aiming to go public through the 18C special technology channel on the main board [1][3] Financial Performance - In 2024, Kanopu's revenue is projected to be 234 million yuan, approximately 258 million HKD, just meeting the 250 million HKD listing threshold for commercialized companies [2][5] - The company's R&D expenditure is 36 million yuan, accounting for 15.4% of its revenue, closely aligning with the requirement of at least 15% for listing [2][6] - R&D spending has been declining year-on-year, with core patents mostly obtained over ten years ago [2][7] - Kanopu's operating cash flow has been negative for two consecutive years, and accounts payable has significantly increased, indicating urgent need for listing [11][21] Market Position - Kanopu is the largest welding robot manufacturer in China and ranks first among Chinese manufacturers in key welding robot segments, including laser welding and cutting robots [19] - Despite its leading position in terms of gross margin, Kanopu's revenue scale remains small compared to comparable companies like Estun and Efort [19][21] - The company achieved a net profit of 8 million yuan in the first half of the year, becoming one of the few in the industry to turn a profit [21] Dependency on Subsidies - Government subsidies have significantly contributed to Kanopu's revenue, with amounts of 40.1 million, 20.8 million, and 10.3 million yuan recorded from 2022 to 2024, and 5.7 million yuan in the first half of the current year, making up 67% of the net profit [11][21] - The proportion of overseas revenue has been declining, from 15.6% in 2022 to 9.1% in the first half of 2023, which may pressure future performance [11][21] Listing Strategy - The 18C special technology company listing rules allow companies to go public without profitability, significantly easing the requirements for profitability and market capitalization [4][14] - For commercialized companies, the market capitalization must be no less than 4 billion HKD, and R&D expenditure must be at least 15% of operating expenses over the last three years [5][15]